Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sudden Hearing Loss and Coronavirus Disease 2019: The Role of Corticosteroid Intra-Tympanic Injection in Hearing Improvement Publisher Pubmed



Rahimi V1 ; Asiyabar MK2 ; Rouhbakhsh N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Audiology, School of Rehabilitation, Tehran University of Medical Sciences, Tehran, Iran
  2. 2. Ent and Head and Neck Research Center and Department, Hazrate Rasoul Hospital, Five Senses Health Institute, Iran University of Medical Sciences, Tehran, Iran

Source: Journal of Laryngology and Otology Published:2021


Abstract

Background Coronavirus disease 2019 was first seen in December 2019. Due to the insidious and complex nature of the disease, the list of symptoms is rapidly expanding. So far, few studies have reported sudden sensorineural hearing loss as a possible symptom of coronavirus disease 2019. Case report A 60-year-old woman with a complaint of sudden sensorineural hearing loss and subjective severe tinnitus presented to the ENT clinic. Coronavirus disease 2019 was subsequently confirmed with a polymerase chain reaction test. At the time of presentation, she was treated with intra-tympanic dexamethasone. Improvements in hearing threshold and speech perception, and a subjective reduction in tinnitus, were observed after treatment. Conclusion This case report supports evidence from other case reports of a possible association between coronavirus disease 2019 and sudden sensorineural hearing loss. Sudden sensorineural hearing loss may be a symptom of this disease that behaves as an underlying aggravating factor. Intra-tympanic injection of corticosteroids is recommended for managing these patients during the pandemic. Copyright © The Author(s), 2021. Published by Cambridge University Press.
Related Docs
View other Related Docs
1. The Relationship Between Sudden Sensorineural Hearing Loss, Vestibular Neuritis, and Infection With Covid-19, Journal of Modern Rehabilitation (2021)
2. Research Paper: Auditory and Vestibular Complaints Among Covid-19 Patients: A Descriptive Survey of 300 Young Patients Over a 3-Month Follow-Up Period, Journal of Modern Rehabilitation (2022)
3. Storm at the Time of Corona: A Glimpse at the Current Understanding and Therapeutic Opportunities of the Sars-Cov-2 Cytokine Storm, Current Pharmaceutical Design (2021)
4. The Clinical Value of Two Combination Regimens in the Management of Patients Suffering From Covid-19 Pneumonia: A Single Centered, Retrospective, Observational Study, DARU# Journal of Pharmaceutical Sciences (2020)
5. Sars-Cov-2: Current Trends in Emerging Variants, Pathogenesis, Immune Responses, Potential Therapeutic, and Vaccine Development Strategies, International Immunopharmacology (2021)
6. Immunology, Immunopathogenesis and Immunotherapeutics of Covid-19; an Overview, International Immunopharmacology (2021)
7. Pregnant Women and Infants Against the Infection Risk of Covid-19: A Review of Prenatal and Postnatal Symptoms, Clinical Diagnosis, Adverse Maternal and Neonatal Outcomes, and Available Treatments, Archives of Gynecology and Obstetrics (2022)
8. Covid-19 and Multiorgan Failure: A Narrative Review on Potential Mechanisms, Journal of Molecular Histology (2020)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (11)
Nematollah Rouhbakhsh (3)
Other Related Docs
9. Pharmacological Treatments of Covid-19, Pharmacological Reports (2020)
10. Immune-Epidemiological Parameters of the Novel Coronavirus–A Perspective, Expert Review of Clinical Immunology (2020)
11. A Review on Currently Available Potential Therapeutic Options for Covid-19, International Journal of General Medicine (2020)
12. Neutrophil Elastase Inhibitor (Sivelestat) May Be a Promising Therapeutic Option for Management of Acute Lung Injury/Acute Respiratory Distress Syndrome or Disseminated Intravascular Coagulation in Covid-19, Journal of Clinical Pharmacy and Therapeutics (2020)
13. Complement Inhibition: A Possible Therapeutic Approach in the Fight Against Covid-19, Reviews in Medical Virology (2022)
14. Prevalence of Toxoplasma Gondii Infection in Covid-19 Patients: A Systematic Review and Meta-Analysis, Microbial Pathogenesis (2024)
15. The Role of Mesenchymal Stromal Cells in Immune Modulation of Covid-19: Focus on Cytokine Storm, Stem Cell Research and Therapy (2020)
16. Recent Findings on the Coronavirus Disease 2019 (Covid-19); Immunopathogenesis and Immunotherapeutics, International Immunopharmacology (2020)
17. Mesenchymal Stromal/Stem Cells (Mscs) and Msc-Derived Extracellular Vesicles in Covid-19-Induced Ards: Mechanisms of Action, Research Progress, Challenges, and Opportunities, International Immunopharmacology (2021)
18. Geriatric Challenges in the New Coronavirus Disease-19 (Covid-19) Pandemic: A Systematic Review, Medical Journal of the Islamic Republic of Iran (2020)
19. Th17 and Treg Cells Function in Sars-Cov2 Patients Compared With Healthy Controls, Journal of Cellular Physiology (2021)
20. B-Cell Depleting Therapies May Affect Susceptibility to Acute Respiratory Illness Among Patients With Multiple Sclerosis During the Early Covid-19 Epidemic in Iran, Multiple Sclerosis and Related Disorders (2020)
21. Cardiovascular Disease in Covid-19: A Systematic Review and Meta-Analysis of 10,898 Patients and Proposal of a Triage Risk Stratification Tool, Egyptian Heart Journal (2020)
22. Covid-19 Cytokine Storm Complications in Asthmatic Patients, Open Public Health Journal (2020)
23. Covid-19 Infection and Stroke Risk, Reviews in the Neurosciences (2021)
24. Photobiomodulation and Antiviral Photodynamic Therapy in Covid-19 Management, Advances in Experimental Medicine and Biology (2021)
25. T Lymphocyte Characteristic Changes Under Serum Cytokine Deviations and Prognostic Factors of Covid-19 in Pregnant Women, Applied Biochemistry and Biotechnology (2023)
26. Biomarker Based Biosensors: An Opportunity for Diagnosis of Covid-19, Reviews in Medical Virology (2022)
27. The Immune System As a Target for Therapy of Sars-Cov-2: A Systematic Review of the Current Immunotherapies for Covid-19, Life Sciences (2020)
28. Melatonin Could Be Beneficial in Sars-Cov-2 Therapy, Natural Products Journal (2021)
29. The Immunologic Basis of Covid-19: A Clinical Approach, Journal of Cellular and Molecular Anesthesia (2020)
30. A Review on Hematologic Malignant Patients Infected With 2019 Novel Coronavirus, Archives of Clinical Infectious Diseases (2020)
31. Serum C-Reactive Protein Greater Than 75 Mg/Dl As an Early Available Laboratory Predictor of Severe Covid-19: A Systematic Review, Immunity# Inflammation and Disease (2023)
32. Cardiac Injury Is Associated With Severe Outcome and Death in Patients With Coronavirus Disease 2019 (Covid-19) Infection: A Systematic Review and Meta-Analysis of Observational Studies, European Heart Journal: Acute Cardiovascular Care (2020)
33. Invasive Airway Intubation in Covid-19 Patients; Statistics, Causes, and Recommendations: A Review Article, Anesthesiology and Pain Medicine (2021)
34. Dysregulation of the Immune Response in Coronavirus Disease 2019, Cell Biology International (2021)
35. A Review of Covid-19: The Main Ways of Transmission and Some Prevention Solutions, Clinical Symptoms, More Vulnerable Human Groups, Risk Factors, Diagnosis, and Treatment, Journal of Environmental Treatment Techniques (2020)
36. Advances in Immunotherapy for Covid-19: A Comprehensive Review, International Immunopharmacology (2021)
37. Covid-19 and Substance Use Disorders: Recommendations to a Comprehensive Healthcare Response. an International Society of Addiction Medicine Practice and Policy Interest Group Position Paper, Basic and Clinical Neuroscience (2020)
38. Evaluation of Mir-200C-3P and Mir-421-5P Levels During Immune Responses in the Admitted and Recovered Covid-19 Subjects, Infection# Genetics and Evolution (2022)
39. Comparison of Immune Response Between Sars, Mers, and Covid-19 Infection, Perspective on Vaccine Design and Development, BioMed Research International (2021)
40. Exosomes From Adipose Tissue-Derived Mesenchymal Stem Cells Induce Regulatory T Cells in Covid‐19 Patients, Iranian Journal of Allergy# Asthma and Immunology (2023)
41. Immune-Based Therapeutic Approaches in Covid-19, Biomedicine and Pharmacotherapy (2022)
42. Demographics, Laboratory Parameters and Outcomes of 1061 Patients With Coronavirus Disease 2019: A Report From Tehran, Iran, New Microbes and New Infections (2020)
43. Covid-19 Pandemic and Biological Therapy in Rheumatologic Disorders: How to Deal With?, Reumatismo (2020)
44. Extrapulmonary Manifestations of Covid-19: Radiologic and Clinical Overview, Clinical Imaging (2020)
45. What Dentists Need to Know About Covid-19, Oral Oncology (2020)
46. Sars-Cov-2: A Comprehensive Review From Pathogenicity of the Virus to Clinical Consequences, Journal of Medical Virology (2020)
47. Wharton's Jelly-Mesenchymal Stem Cells Treatment for Severe Covid 19 Patients: 1-Year Follow-Up, Gene Reports (2022)
48. Nano Antiviral Photodynamic Therapy: A Probable Biophysicochemical Management Modality in Sars-Cov-2, Expert Opinion on Drug Delivery (2021)
49. Covid-19’S Immuno-Pathology and Cardiovascular Diseases, Journal of Investigative Medicine (2023)
50. Covid-19: Our Current Knowledge of Epidemiology, Pathology, Therapeutic Approaches, and Diagnostic Methods, Anti-Cancer Agents in Medicinal Chemistry (2021)